Modified AutoSet Device vs Existing AutoSet Device, the Assessment of Efficacy and Subjective Comfort of the Treatment.

February 25, 2021 updated by: ResMed

Comparison of the Efficacy and Subjective Comfort of a Modified AutoSet Device With an Existing AutoSet Device (VPAP Auto) in Treating Obstructive Sleep Apnea

The purpose of this study is to determine if the performance of the modified AutoSet device is equivalent or better than the existing AutoSet device (VPAP Auto) in the efficacy of the treatment and the subjective comfort.

Study Overview

Status

Completed

Conditions

Detailed Description

Obstructive sleep apnea (OSA) is characterised by a partial or complete collapse of the upper airway during sleep. The treatment of choice for OSA is Continuous Positive Airway Pressure (CPAP). CPAP acts as a positive airway splint, delivering a fixed or auto adjusted positive pressure to the upper airway via a tube and mask. The modified device to be assessed in this study will act in a similar way to the existing device, VPAP Auto, but utilizes an improved algorithm which should maintain or enhance the effectiveness of the treatment.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New South Wales
      • Bella Vista, New South Wales, Australia, 2135
        • Centre for Healthy Sleep

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients aged 18-80 years
  • Patients who are on CPAP therapy in AUTOSET mode for no less than 6 months
  • Patients who are using ResMed masks

Exclusion Criteria:

  • Patients who are unable to provide written informed consent
  • Patients who are unable to comprehend written and spoken English
  • Patients who are using Bilevel PAP
  • Patients who are pregnant
  • Patients who are suffering any of the following:

    • Acute respiratory infection
    • Acute sinusitis, otitis media or perforated eardrum
    • Pneumothorax or pneumomediastinum
    • Recent history of severe epistaxis requiring medical attention

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Nexus Flow Generator
Participants were randomised to Nexus Flow Generator group for one night.
The modified device to be assessed in this study will act in a similar way to the existing device, VPAP Auto, but utilises an improved algorithm which should maintain or enhance the effectiveness of the treatment.
ACTIVE_COMPARATOR: VPAP Flow Generator 25
Participants were randomised to VPAP Flow Generator 25 group for one night.
Exiting VPAP Auto 25 Flow Generator with A10 Algorithm

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Apnoea-Hypopnoea Index (AHI)
Time Frame: One Night On Each Arm, approximately 8 hours each night
The number of apneas and hypopnoeas per hour of sleep measured on Nexus Auto & VPAP Auto 25
One Night On Each Arm, approximately 8 hours each night
Oxygen Desaturation Index
Time Frame: One Night On Each Arm, approximately 8 hours each night
Number of oxygen desaturations per hour of sleep
One Night On Each Arm, approximately 8 hours each night

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comfort of Breathing
Time Frame: One Night On Each Arm, approximately 8 hours each night
Participant's Comfort Rating in one question: How comfortable/uncomfortable was the CPAP device to breathe on? Ratings from 0 (very uncomfortable) to 10 (very comfortable) on a Likert Scale
One Night On Each Arm, approximately 8 hours each night
Satisfaction of Treatment
Time Frame: One Night On Each Arm, approximately 8 hours each night
Participant's treatment satisfaction in one question: How much did the CPAP disturb your sleep last night? Rating from 0 (a lot) to 10 (not at all) on a Likert Scale
One Night On Each Arm, approximately 8 hours each night
Refreshed Feel
Time Frame: One Night On Each Arm, approximately 8 hours each night
Participants rated 0 (not refreshed at all) to 10 (very refreshed) on Likert Scale on one question: How refreshed did you feel this morning?
One Night On Each Arm, approximately 8 hours each night

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 11, 2009

Primary Completion (ACTUAL)

June 15, 2009

Study Completion (ACTUAL)

June 15, 2009

Study Registration Dates

First Submitted

May 13, 2009

First Submitted That Met QC Criteria

May 20, 2009

First Posted (ESTIMATE)

May 21, 2009

Study Record Updates

Last Update Posted (ACTUAL)

March 22, 2021

Last Update Submitted That Met QC Criteria

February 25, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep Apnea

Clinical Trials on Nexus Flow Generator

3
Subscribe